Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retraction Note: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma.
Chan TC, Pan CT, Hsieh HY, Vejvisithsakul PP, Wei RJ, Yeh BW, Wu WJ, Chen LR, Shiao MS, Li CF, Shiue YL. Chan TC, et al. Among authors: vejvisithsakul pp. Cell Oncol (Dordr). 2024 Oct 17. doi: 10.1007/s13402-024-01006-9. Online ahead of print. Cell Oncol (Dordr). 2024. PMID: 39419942 No abstract available.
Corrigendum to: "Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer" [Int. J. Biol Macromol. 245 (2023) Jun 21; 125510/Online ahead of print. PMID: 37353120; IJBIOMAC-D-23-03903R1].
Kianpour M, Huang CW, Vejvisithsakul PP, Wang JY, Li CF, Shiao MS, Pan CT, Shiue YL. Kianpour M, et al. Among authors: vejvisithsakul pp. Int J Biol Macromol. 2023 Sep 1;248:125782. doi: 10.1016/j.ijbiomac.2023.125782. Epub 2023 Jul 21. Int J Biol Macromol. 2023. PMID: 37481838 No abstract available.
The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma.
Chan TC, Pan CT, Hsieh HY, Vejvisithsakul PP, Wei RJ, Yeh BW, Wu WJ, Chen LR, Shiao MS, Li CF, Shiue YL. Chan TC, et al. Among authors: vejvisithsakul pp. Cell Oncol (Dordr). 2023 Aug;46(4):933-951. doi: 10.1007/s13402-023-00788-8. Epub 2023 Mar 15. Cell Oncol (Dordr). 2023. Retraction in: Cell Oncol (Dordr). 2024 Oct 17. doi: 10.1007/s13402-024-01006-9. PMID: 36920729 Retracted.